Yousif Capital Management LLC Sells 2,286 Shares of The Clorox Company (NYSE:CLX)

Yousif Capital Management LLC cut its stake in The Clorox Company (NYSE:CLX - Free Report) by 3.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,149 shares of the company's stock after selling 2,286 shares during the quarter. Yousif Capital Management LLC's holdings in Clorox were worth $8,562,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Redwood Park Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter valued at about $26,000. Millstone Evans Group LLC purchased a new stake in shares of Clorox during the fourth quarter valued at approximately $31,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Clorox during the fourth quarter valued at approximately $31,000. Asset Planning Inc acquired a new position in shares of Clorox during the fourth quarter worth $32,000. Finally, GKV Capital Management Co. Inc. purchased a new position in shares of Clorox in the fourth quarter valued at $32,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.57% of the company's stock.

Clorox Stock Down 3.3%

NYSE CLX traded down $4.25 on Friday, reaching $123.03. The stock had a trading volume of 1,709,082 shares, compared to its average volume of 1,361,693. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1 year low of $122.84 and a 1 year high of $171.37. The business has a 50 day moving average price of $134.91 and a 200 day moving average price of $148.48. The company has a market capitalization of $15.16 billion, a price-to-earnings ratio of 33.61, a P/E/G ratio of 2.62 and a beta of 0.54.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company's quarterly revenue was down 8.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.71 EPS. On average, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CLX shares. Wells Fargo & Company dropped their price target on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. JPMorgan Chase & Co. cut their price target on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Evercore ISI set a $140.00 price target on Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Morgan Stanley dropped their price objective on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Finally, Barclays cut their target price on Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a research report on Wednesday, May 7th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $151.23.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.